Heather Tye

This inventor holds 18 USPTO granted patents and 4 published patent applications and 15 EPO patents, primarily in Pharmaceutical Inhibitors. Top assignees: Boehringer Ingelheim International Gmbh, Padlock Therapeutics, Inc., Raze Therapeutics, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heather Tye. Retrieved from https://idiyas.com/inventor/heather-tye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 15 (Patent Applications = 16)

Average Co-Inventor Count = 10.1

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

East Hagbourne, GB (2013 - 2016)
Oxfordshire, GB (2013 - 2022)
Abingdon, GB (2013 - 2024)

Company Filing History:

9 out of 1,562

Boehringer Ingelheim International Gmbh

patents

6 out of 6

Padlock Therapeutics, Inc.

patents

2 out of 8

Raze Therapeutics, Inc.

patents

4. 1 out of 1,335

Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V.

patents

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Caffeine Inhibitors

MTHFD2

PAD4

Leukotriene Production

Bicyclic Inhibitors

Covalent Inhibitors

Heterocyclic Compounds

Serotonin Receptor

Oxadiazole Inhibitors

Aza-Benzimidazole

Pharmaceutical Compositions

Benzylic Oxindole

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12187728 - Caffeine inhibitors of MTHFD2 and uses thereof (2025-01-07),

2. 11897866 - Heteroaryl inhibitors of PAD4 (2024-02-13),

3. 11370792 - Caffeine inhibitors of MTHFD2 and uses thereof (2022-06-28),

4. 11198681 - Heteroaryl inhibitors of PAD4 (2021-12-14),

5. 11026937 - Heteroaryl inhibitors of PAD4 (2021-06-08),

6. 10703741 - Covalent inhibitors of PAD4 (2020-07-07),

7. 9963462 - Sepiapterin reductase inhibitors (2018-05-08),

8. 9963448 - Bicyclic inhibitors of PAD4 (2018-05-08),

9. 9765093 - Aza-benzimidazole inhibitors of PAD4 (2017-09-19),

10. 9346816 - 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them (2016-05-24),

11. 9174980 - Heterocyclic compounds as inhibitors of leukotriene production (2015-11-03),

12. 8658661 - Oxadiazole inhibitors of leukotriene production (2014-02-25),

13. 8609696 - Serotonin 5-HT2B receptor inhibitors (2013-12-17),

14. 8580829 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

15. 8580825 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

Title: The Innovative Mind of Heather Tye

Introduction: Heather Tye, a pioneering inventor hailing from Abingdon, GB, is a remarkable woman whose creative spirit has led to groundbreaking innovations in various fields.

Latest Patents: Heather Tye's latest patents include a revolutionary eco-friendly packaging solution that has garnered international acclaim for its sustainability and efficiency.

Career Highlights: With a career spanning over two decades, Heather Tye has consistently pushed the boundaries of traditional thinking, with her inventions revolutionizing industries such as renewable energy, healthcare, and consumer goods.

Collaborations: Throughout her career, Heather Tye has collaborated with leading research institutions, universities, and forward-thinking companies to bring her visionary ideas to life. Her ability to work seamlessly across disciplines has resulted in the development of cutting-edge technologies that have changed the way we live and work.

Conclusion: Heather Tye's passion for innovation, coupled with her relentless drive to make a positive impact on the world, cements her status as a trailblazing inventor whose contributions will continue to inspire future generations.

Profile summary based on public USPTO records.